HEADER HYDROLASE 25-NOV-22 8BSN TITLE HUMAN GLS IN COMPLEX WITH COMPOUND 27 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL 65 KDA CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: KIDNEY; SOURCE 6 GENE: GLS, GLS1, KIAA0838; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS HYDROLASE, GLUTAMINASE, THIADIAZOLE, PYRIDAZINE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DEBRECZENI REVDAT 1 18-JAN-23 8BSN 0 JRNL AUTH M.R.V.FINLAY,M.ANDERTON,A.BAILEY,S.BOYD,J.BROOKFIELD, JRNL AUTH 2 C.CAIRNDUFF,M.CHARLES,A.CHEASTY,S.E.CRITCHLOW,J.CULSHAW, JRNL AUTH 3 T.EKWURU,I.HOLLINGSWORTH,N.JONES,F.LEROUX,M.LITTLESON, JRNL AUTH 4 H.MCCARRON,J.MCKELVIE,L.MOONEY,J.W.M.NISSINK,D.PERKINS, JRNL AUTH 5 S.POWELL,M.J.QUESADA,P.RAUBO,V.SABIN,J.SMITH,P.D.SMITH, JRNL AUTH 6 A.STARK,A.TING,P.WANG,Z.WILSON,J.J.WINTER-HOLT,J.M.WOOD, JRNL AUTH 7 G.L.WRIGLEY,G.YU,P.ZHANG JRNL TITL DISCOVERY OF A THIADIAZOLE-PYRIDAZINE-BASED ALLOSTERIC JRNL TITL 2 GLUTAMINASE 1 INHIBITOR SERIES THAT DEMONSTRATES ORAL JRNL TITL 3 BIOAVAILABILITY AND ACTIVITY IN TUMOR XENOGRAFT MODELS. JRNL REF J MED CHEM V. 62 6540 2019 JRNL REFN ISSN 1520-4804 JRNL PMID 31199640 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00260 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 27655 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1391 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.51 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.50 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2614 REMARK 3 BIN FREE R VALUE : 0.3682 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 28 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2378 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 20 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.92990 REMARK 3 B22 (A**2) : 7.92990 REMARK 3 B33 (A**2) : -15.85980 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.320 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.186 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.154 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.188 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.156 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2488 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3369 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 831 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 420 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2488 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 308 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1596 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.95 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.26 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.90 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|222 - A|532 } REMARK 3 ORIGIN FOR THE GROUP (A): -7.2771 15.45 23.2516 REMARK 3 T TENSOR REMARK 3 T11: 0.2584 T22: 0.0066 REMARK 3 T33: 0.0996 T12: 0.0262 REMARK 3 T13: 0.0388 T23: -0.0401 REMARK 3 L TENSOR REMARK 3 L11: 2.246 L22: 2.5806 REMARK 3 L33: 2.4773 L12: 0.0169 REMARK 3 L13: 0.3309 L23: 0.256 REMARK 3 S TENSOR REMARK 3 S11: -0.0251 S12: 0.313 S13: 0.0488 REMARK 3 S21: 0.313 S22: 0.0245 S23: -0.1487 REMARK 3 S31: 0.0488 S32: -0.1487 S33: 0.0006 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8BSN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1292126986. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27670 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.490 REMARK 200 RESOLUTION RANGE LOW (A) : 29.460 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 10.80 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 9.80 REMARK 200 R MERGE FOR SHELL (I) : 0.76000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8M LITHIUM SULPHATE 0.1M BISTRIS PH REMARK 280 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 -X+1/2,Y,-Z+3/4 REMARK 290 6555 X,-Y+1/2,-Z+1/4 REMARK 290 7555 Y+1/2,X+1/2,-Z+1/2 REMARK 290 8555 -Y,-X,-Z REMARK 290 9555 X+1/2,Y+1/2,Z+1/2 REMARK 290 10555 -X,-Y,Z REMARK 290 11555 -Y+1/2,X,Z+3/4 REMARK 290 12555 Y,-X+1/2,Z+1/4 REMARK 290 13555 -X,Y+1/2,-Z+1/4 REMARK 290 14555 X+1/2,-Y,-Z+3/4 REMARK 290 15555 Y,X,-Z REMARK 290 16555 -Y+1/2,-X+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 70.24200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 70.24200 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.69900 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 70.24200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.34950 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 70.24200 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 118.04850 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 70.24200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 118.04850 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 70.24200 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 39.34950 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 70.24200 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 70.24200 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 78.69900 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 70.24200 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 70.24200 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 78.69900 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 11 0.000000 -1.000000 0.000000 70.24200 REMARK 290 SMTRY2 11 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 1.000000 118.04850 REMARK 290 SMTRY1 12 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 12 -1.000000 0.000000 0.000000 70.24200 REMARK 290 SMTRY3 12 0.000000 0.000000 1.000000 39.34950 REMARK 290 SMTRY1 13 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 70.24200 REMARK 290 SMTRY3 13 0.000000 0.000000 -1.000000 39.34950 REMARK 290 SMTRY1 14 1.000000 0.000000 0.000000 70.24200 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 14 0.000000 0.000000 -1.000000 118.04850 REMARK 290 SMTRY1 15 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 15 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 16 0.000000 -1.000000 0.000000 70.24200 REMARK 290 SMTRY2 16 -1.000000 0.000000 0.000000 70.24200 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 78.69900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 44340 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -291.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 S SO4 A 602 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 219 REMARK 465 MET A 220 REMARK 465 ILE A 221 REMARK 465 LEU A 533 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 316 CG CD1 CD2 REMARK 470 ARG A 317 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 318 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 383 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 ND2 ASN A 529 ND2 ASN A 529 10555 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 285 -125.61 57.29 REMARK 500 PHE A 318 40.47 -104.53 REMARK 500 TYR A 466 -136.10 53.13 REMARK 500 VAL A 495 -63.02 -128.06 REMARK 500 REMARK 500 REMARK: NULL DBREF 8BSN A 221 533 UNP O94925 GLSK_HUMAN 221 533 SEQADV 8BSN SER A 219 UNP O94925 EXPRESSION TAG SEQADV 8BSN MET A 220 UNP O94925 EXPRESSION TAG SEQRES 1 A 315 SER MET ILE PRO ASP PHE MET SER PHE THR SER HIS ILE SEQRES 2 A 315 ASP GLU LEU TYR GLU SER ALA LYS LYS GLN SER GLY GLY SEQRES 3 A 315 LYS VAL ALA ASP TYR ILE PRO GLN LEU ALA LYS PHE SER SEQRES 4 A 315 PRO ASP LEU TRP GLY VAL SER VAL CYS THR VAL ASP GLY SEQRES 5 A 315 GLN ARG HIS SER THR GLY ASP THR LYS VAL PRO PHE CYS SEQRES 6 A 315 LEU GLN SER CYS VAL LYS PRO LEU LYS TYR ALA ILE ALA SEQRES 7 A 315 VAL ASN ASP LEU GLY THR GLU TYR VAL HIS ARG TYR VAL SEQRES 8 A 315 GLY LYS GLU PRO SER GLY LEU ARG PHE ASN LYS LEU PHE SEQRES 9 A 315 LEU ASN GLU ASP ASP LYS PRO HIS ASN PRO MET VAL ASN SEQRES 10 A 315 ALA GLY ALA ILE VAL VAL THR SER LEU ILE LYS GLN GLY SEQRES 11 A 315 VAL ASN ASN ALA GLU LYS PHE ASP TYR VAL MET GLN PHE SEQRES 12 A 315 LEU ASN LYS MET ALA GLY ASN GLU TYR VAL GLY PHE SER SEQRES 13 A 315 ASN ALA THR PHE GLN SER GLU ARG GLU SER GLY ASP ARG SEQRES 14 A 315 ASN PHE ALA ILE GLY TYR TYR LEU LYS GLU LYS LYS CYS SEQRES 15 A 315 PHE PRO GLU GLY THR ASP MET VAL GLY ILE LEU ASP PHE SEQRES 16 A 315 TYR PHE GLN LEU CYS SER ILE GLU VAL THR CYS GLU SER SEQRES 17 A 315 ALA SER VAL MET ALA ALA THR LEU ALA ASN GLY GLY PHE SEQRES 18 A 315 CYS PRO ILE THR GLY GLU ARG VAL LEU SER PRO GLU ALA SEQRES 19 A 315 VAL ARG ASN THR LEU SER LEU MET HIS SER CYS GLY MET SEQRES 20 A 315 TYR ASP PHE SER GLY GLN PHE ALA PHE HIS VAL GLY LEU SEQRES 21 A 315 PRO ALA LYS SER GLY VAL ALA GLY GLY ILE LEU LEU VAL SEQRES 22 A 315 VAL PRO ASN VAL MET GLY MET MET CYS TRP SER PRO PRO SEQRES 23 A 315 LEU ASP LYS MET GLY ASN SER VAL LYS GLY ILE HIS PHE SEQRES 24 A 315 CYS HIS ASP LEU VAL SER LEU CYS ASN PHE HIS ASN TYR SEQRES 25 A 315 ASP ASN LEU HET SO4 A 601 5 HET SO4 A 602 5 HET SO4 A 603 5 HET SO4 A 604 5 HET SO4 A 605 5 HET R0C A 606 29 HETNAM SO4 SULFATE ION HETNAM R0C (2~{S})-2-METHOXY-2-PHENYL-~{N}-[5-[[(3~{R})-1- HETNAM 2 R0C PYRIDAZIN-3-YLPYRROLIDIN-3-YL]AMINO]-1,3,4-THIADIAZOL- HETNAM 3 R0C 2-YL]ETHANAMIDE FORMUL 2 SO4 5(O4 S 2-) FORMUL 7 R0C C19 H21 N7 O2 S FORMUL 8 HOH *20(H2 O) HELIX 1 AA1 ASP A 223 LYS A 240 1 18 HELIX 2 AA2 ILE A 250 LYS A 255 1 6 HELIX 3 AA3 GLN A 285 CYS A 287 5 3 HELIX 4 AA4 VAL A 288 GLY A 301 1 14 HELIX 5 AA5 GLY A 301 HIS A 306 1 6 HELIX 6 AA6 VAL A 334 SER A 343 1 10 HELIX 7 AA7 ASN A 350 ALA A 366 1 17 HELIX 8 AA8 SER A 374 GLY A 385 1 12 HELIX 9 AA9 GLY A 385 LYS A 398 1 14 HELIX 10 AB1 ASP A 406 SER A 419 1 14 HELIX 11 AB2 THR A 423 ASN A 436 1 14 HELIX 12 AB3 SER A 449 GLY A 464 1 16 HELIX 13 AB4 MET A 465 ASP A 467 5 3 HELIX 14 AB5 PHE A 468 VAL A 476 1 9 HELIX 15 AB6 SER A 511 ASN A 526 1 16 SHEET 1 AA1 2 LYS A 245 VAL A 246 0 SHEET 2 AA1 2 PRO A 504 LEU A 505 -1 O LEU A 505 N LYS A 245 SHEET 1 AA2 5 ARG A 272 GLY A 276 0 SHEET 2 AA2 5 GLY A 262 THR A 267 -1 N VAL A 265 O HIS A 273 SHEET 3 AA2 5 MET A 496 TRP A 501 -1 O GLY A 497 N CYS A 266 SHEET 4 AA2 5 GLY A 487 VAL A 492 -1 N LEU A 490 O MET A 498 SHEET 5 AA2 5 ALA A 480 SER A 482 -1 N LYS A 481 O LEU A 489 SHEET 1 AA3 3 PHE A 282 CYS A 283 0 SHEET 2 AA3 3 ILE A 420 VAL A 422 -1 O VAL A 422 N PHE A 282 SHEET 3 AA3 3 GLY A 372 PHE A 373 -1 N GLY A 372 O GLU A 421 CRYST1 140.484 140.484 157.398 90.00 90.00 90.00 I 41 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007118 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007118 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006353 0.00000